SMITH ASSET MANAGEMENT GROUP LP - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 95 filers reported holding ZIOPHARM ONCOLOGY INC in Q2 2014. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.

Quarter-by-quarter ownership
SMITH ASSET MANAGEMENT GROUP LP ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q4 2014$1,090,000
+74.4%
214,970
-9.1%
0.04%
+65.2%
Q3 2014$625,000
-34.7%
236,590
-0.3%
0.02%
-34.3%
Q2 2014$957,000
+36.9%
237,410
+55.5%
0.04%
+29.6%
Q1 2014$699,000152,6600.03%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q2 2014
NameSharesValueWeighting ↓
MSD Partners, L.P. 10,986,258$20,544,0001.80%
Third Security, LLC 4,364,080$8,161,0001.11%
MILLER VALUE PARTNERS, LLC 9,264,700$16,617,0000.75%
Sargent Investment Group, LLC 188,950$353,0000.22%
Chessman Wealth Strategies RIA 72,050$135,0000.14%
Ibex Investors LLC 403,650$755,0000.12%
Old West Investment Management, LLC 223,319$417,0000.11%
PIPER SANDLER & CO. 34,222$64,0000.07%
Virtus ETF Advisers LLC 102,888$192,0000.03%
G&S Capital LLC 18,000$34,0000.03%
View complete list of ZIOPHARM ONCOLOGY INC shareholders